Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Scopus BioPharma Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q4 2021
- Shares held
- 1.01M
- −1.87M (−65.0%) vs. Q4 2021
- Total value
- $693.0K
- −$4.02M (−85.3%) vs. Q4 2021
- New holders
- 3
- 8 more added
- Sold out
- 4
- 3 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 1 | $7.49K |
| Q3 2022 | 15 | $110.6K |
| Q2 2022 | 17 | $293.0K |
| Q1 2022 | 19 | $693.0K |
| Q4 2021 | 21 | $4.71M |
| Q3 2021 | 14 | $1.14M |
| Q2 2021 | 15 | $1.07M |
| Q1 2021 | 28 | $4.89M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Scopus BioPharma Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 100 | $0 | 0.00% | −4,740−97.9% | Reduced |
| Wells Fargo & Company | 82 | $0 | 0.00% | +19+30.2% | Added |
| Morgan Stanley | 2,109 | $1.00K | 0.00% | −41,903−95.2% | Reduced |
| Royal Bank of Canada | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Compagnie Lombard Odier SCmA | 4,360 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,187 | $6.00K | 0.00% | +3,450+60.1% | Added |
| Northern Trust Corp | 12,516 | $9.00K | 0.00% | 00.0% | Unchanged |
| Moors & Cabot, Inc. | 14,500 | $10.0K | 0.00% | +14,500 | New |
| State Street Corp | 20,729 | $14.0K | 0.00% | +829+4.2% | Added |
| Susquehanna International Group, LLP | 20,723 | $14.0K | 0.00% | +20,723 | New |
| First Manhattan Co | 25,800 | $17.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 30,229 | $21.0K | 0.00% | +15,198+101.1% | Added |
| BlackRock Inc. | 36,675 | $25.0K | 0.00% | +17,147+87.8% | Added |
| Bridgeway Capital Management, LLC | 67,966 | $47.0K | 0.00% | −26,000−27.7% | Reduced |
| M&R Capital Management Inc | 76,819 | $53.0K | 0.01% | +76,819 | New |
| Renaissance Technologies LLC | 112,523 | $78.0K | 0.00% | +91,623+438.4% | Added |
| Geode Capital Management, LLC | 203,805 | $140.0K | 0.00% | +137,684+208.2% | Added |
| Vanguard Group Inc | 364,441 | $251.0K | 0.00% | +1,400+0.4% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,100,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −30,403−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −27,043−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,897−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |